Safety and efficacy of aprotinin under conditions of deep hypothermia and circulatory arrest
Open Access
- 1 December 1995
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 110 (6) , 1615-1621
- https://doi.org/10.1016/s0022-5223(95)70021-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Safety of aprotinin in profound hypothermia and circulatory arrestThe Annals of Thoracic Surgery, 1994
- Aprotinin reduces cardiopulmonary bypass‐induced blood loss and inhibits fibrinolysis without influencing plateletsBritish Journal of Haematology, 1993
- Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrestThe Annals of Thoracic Surgery, 1993
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992
- High-dose aprotinin in cardiac surgery: Three years' experience in 1,784 patientsJournal of Cardiothoracic and Vascular Anesthesia, 1992
- Effect of aprotinin on neutrophil function after major vascular surgeryBritish Journal of Surgery, 1992
- Aprotinin in cardiopulmonary bypass- effects on the Hageman factor (FXII)-Kallikrein system and blood lossBlood Coagulation & Fibrinolysis, 1992
- Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypassThe Annals of Thoracic Surgery, 1991
- Aprotinin (Trasylol) is a competitive inhibitor of activated protein CThrombosis Research, 1989
- Platelet preservation during cardiopulmonary bypass with aprotininEuropean Journal of Cardio-Thoracic Surgery, 1989